The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...

The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the ...

The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which ...

WASHINGTON — U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own ...

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward ...

The Scottish Medicines Consortium has announced its latest decisions on what new drugs can be used by the NHS in Scotland.

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

FDA approves the first treatment for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), offering new hope for ...

The FDA has granted accelerated approval to the combination therapy of avutometinib and defactinib (Avmapki Fakzynja Co-pack) ...

Avutometinib given with defactinib is now approved for the treatment of adult patients with recurrent low-grade serous, ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Verastem Oncology’s oral combination therapy ...